Information Library
Results for: Connect with investigators, regulators and physicians - Get to market faster
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Quintiles Acquires VCG & Associates and VCG Bio
Press Release — October 19, 2011 – The acquisition of VCG & Associates and VCG BIO strengthens Quintiles’ comprehensive commercial services in sales and brand solutions, product solutions, product distribution and market access.
-
An Integrated Approach to Biosimilar Development & Commercialization
White Paper — September 29, 2011
As the market for biosimilar products continues to grow, many biopharmaceutical companies trying to enter the space are struggling to overcome the unique challenges that developing such products presents. -
Quintiles Reaches New Milestone in Social Health
Press Release — March 28, 2011 – Quintiles announced that its online social community at www.MediGuard.org has reached 2.5 million members in just three years.
-
Podcast: MediGuard's Membership Milestone
Hear from the Experts — March 25, 2011
Hugo Stephenson, President of MediGuard, dicusses the 2.5 million member milestone. -
The Use of Large Simple Trials
Presentation — February 25, 2011
Quintiles presentation at CBI Late Phase Conference explores the design and application of Large Simple Trials as a cost effective approach to delivering high quality observational research data. -
Using Real-Time Data to Drive Better Decisions, Faster
White Paper — September 30, 2010
This white paper examines the advantages afforded by access to real-time data during the course of a clinical trial. -
THE NEW HEALTH REPORT FINDS GREATER INFLUENCE FOR PATIENTS ON DRUG DEVELOPMENT
Press Release — June 15, 2010 - Patients are emerging as an increasingly strong group when it comes to influencing the success and failure of new drugs – according to a newly published New Health Report commissioned by Quintiles.
-
Commercial – Identify, Promote and Prove Treatment Value
Brochure — April 1, 2010
Quintiles has built an unmatched suite of commercial competencies that biopharma companies are leveraging for faster market access and sustained success. -
New FDA Guidance on Antidiabetic Therapies
White Paper — December 11, 2009
Understanding the FDA Guidance on Assessing Cardiovascular Risks for new Antidiabetic Therapies. Learn what FDA cardiac safety requirements may mean for your development program. -
Services for Biotechnology
Brochure — July 20, 2009
We Understand the Dynamic Needs of Biotech
